Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-03-08 00:00:00 ET · period of report 2024-03-06 · accession 0001822629-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-08 | 2024-03-06+ | ANIP | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $66.10 | -45.3K | 445.0K | -9% | -$2.99M |
| 2024-03-08 | 2024-03-07 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $66.71 | -17.1K | 427.9K | -4% | -$1.14M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | S | D | 16,292 | $67.13 | 411,629 | D | — | — | (F3) The shares were sold in multiple trades at prices ranging from $66.42 to $67.74. The price reported above reflects the weighted average sales price. |
| 2 | Common | Common Stock | 2024-03-07 | F | D | 17,060 | $66.71 | 427,921 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-06 | S | D | 28,965 | $65.52 | 444,981 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $65.00 to $66.01. The price reported above reflects the weighted average sales price. |